Correlation Between Harpoon Therapeutics and Corvus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Harpoon Therapeutics and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Harpoon Therapeutics and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Harpoon Therapeutics and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Harpoon Therapeutics and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Harpoon Therapeutics with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Harpoon Therapeutics and Corvus Pharmaceuticals.

Diversification Opportunities for Harpoon Therapeutics and Corvus Pharmaceuticals

0.0

Correlation Coefficient

Harpoon Therapeutics  Corvus Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Harpoon and Corvus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Harpoon Therapeutics and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Harpoon Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Harpoon Therapeutics are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Harpoon Therapeutics i.e., Harpoon Therapeutics and Corvus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Harpoon Therapeutics and Corvus Pharmaceuticals

If you would invest (100.00) in Harpoon Therapeutics on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Harpoon Therapeutics or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Harpoon Therapeutics  vs.  Corvus Pharmaceuticals

Harpoon Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Harpoon Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Harpoon Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Corvus Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Corvus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Harpoon Therapeutics and Corvus Pharmaceuticals

The main advantage of trading using opposite Harpoon Therapeutics and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Harpoon Therapeutics position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.

The idea behind Harpoon Therapeutics and Corvus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.